{"name":"Triple Hair Inc","slug":"triple-hair-inc","ticker":"","exchange":"","domain":"triplehair.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Rare Disease","slug":"rare-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Minoxidil 5% Topical Solution","genericName":"Minoxidil 5% Topical Solution","slug":"minoxidil-5-topical-solution","indication":"Androgenetic alopecia (male pattern baldness)","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"TH07","genericName":"TH07","slug":"th07","indication":"Prostate cancer","status":"phase_3"}]}],"pipeline":[{"name":"Minoxidil 5% Topical Solution","genericName":"Minoxidil 5% Topical Solution","slug":"minoxidil-5-topical-solution","phase":"marketed","mechanism":"Minoxidil is a potassium channel opener that increases blood flow to hair follicles and prolongs the anagen (growth) phase of the hair cycle.","indications":["Androgenetic alopecia (male pattern baldness)","Female pattern hair loss"],"catalyst":""},{"name":"TH07","genericName":"TH07","slug":"th07","phase":"phase_3","mechanism":"TH07 is a small molecule that targets the androgen receptor.","indications":["Prostate cancer","Androgenetic alopecia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNQW9IY2lJRVNBV2hMNHEwNml4MXJDMVVxNmh2b05weWRGM214R0ZkTWlJbU1yY082ZWJtNGNxZXhqMEdkUmk1WEVCbVpZbnVaRXNXeXh6SkhabWxrU1AzX3UtWXM1SzQzVE45NUxwRFBhRWM5bVllQjQ3SEVPWWFYeFdtZ25WLTRKdXg1OUF0RFRxcFVyR3dUZEJtQ2Y5ZmI4a2ZCZmhrWG5TQUFlMmZmRnhpaUR6Q2pCMVJNZU5Fekd1N3pfWHZJdTJGRUdiYlVBMk1tTg?oc=5","date":"2026-04-02","type":"trial","source":"BioSpace","summary":"Triple Hair Doses First Patient in Phase III Clinical Trial in Canada for Male Androgenic Alopecia - BioSpace","headline":"Triple Hair Doses First Patient in Phase III Clinical Trial in Canada for Male Androgenic Alopecia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQU3FXWFBhRWprQ1IzWlUxUW5zUUcyYUZIRXVEZ1VzTmYxbE1DZXVRVG5DMHptRnBpd2ZQSzhBM2lDUDVsWjZhanM5Nm1tVEJpaUdMUjYtWWZNTktvazZ3YnFPd3c1LXo3MVprQ09leS1qeDJjUGtVTjVJOHoybmJKaVRJODhKd0IzUU5YMzc5bjd3aEprZnRn?oc=5","date":"2026-03-31","type":"pipeline","source":"Good Housekeeping","summary":"The 12 Best At-Home Hair Color Products, Tested on 136 Women - Good Housekeeping","headline":"The 12 Best At-Home Hair Color Products, Tested on 136 Women","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPQmVMSEktZ0xEWWJTaUEwX0JqMmsxVVBaZktoTzJLSkZONlRMNHJlMjZlaTNqUm9lcXFaQVo1enlhbFpMdTJaTnBITWQydFhWNDVIUzlUOURUNU5WVFZmMHV4blNxZjdud0hyc205eHlWeFBnSzIwOWJzOFhUVWx2VmhJc0xTZE9pbTVhQU4zSGZuQjVnSFV4RmN2XzlBMkg4M1pxcGN6RmhDZw?oc=5","date":"2026-03-16","type":"pipeline","source":"New York Post","summary":"New triple-threat topical treatment fights hair loss better than finasteride and minoxidil - New York Post","headline":"New triple-threat topical treatment fights hair loss better than finasteride and minoxidil","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNb1ltaUlDQkhDN0c4NjhqT09hcXI4RGdualN5WTRYc2ZRTE5JQmhVWHQ3YUM2N2JnelJIMlNRTUZfaEZDdUcxQWE5MUN1OHVkaG9KM1NfXzkzcWp2b0xpT3VuOWgydGV0LXhRNjJRTWQ3UE13bkMwdHFxbWtfN3lOd2hEdXotZXBNYVZNTHBLWXgxWlBqdXZ2bm12QXpKakpqVlY4emEtclhPNEotaEQ2YkdhU1Z6dTNmUjktRlZJcERHbTU2NTVRNlhXNEhTSXpOdldGczBQSDNwNzRkMERJVHc2RU0?oc=5","date":"2026-02-24","type":"pipeline","source":"prnewswire.com","summary":"OLAPLEX Unveils the Next Evolution of Bond Repair with No.3PLUS -- A 3-Minute Hair Transformation - prnewswire.com","headline":"OLAPLEX Unveils the Next Evolution of Bond Repair with No.3PLUS -- A 3-Minute Hair Transformation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE44aEMxa05jZXE2ZXJaT2wtV3FmQmRSSERQUW9WbkM4ZGlmemtJdEE4elZvZW5mdF9XY3hDazE1LUxCdkUtUWwzMlc0VVJPLVRkaTFuQzJONmRPQ3dXWHJIeU1lS3RVQ2lCTW54RXduSUdxUFFUQ21ManFn?oc=5","date":"2025-12-31","type":"pipeline","source":"Dermatology Times","summary":"Top 10 Articles of the Year: 2025 - Dermatology Times","headline":"Top 10 Articles of the Year: 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNYkwtUmVWVDJtNWdpTlFJSDJRbGExc1QzUjg4MXQ5SnNGenNoS093VElqb192dFV1UVNyZkxkVWhtSjdDUmVKd2Ruc3ZPZGJVOUVlXzJYXzJEbkducWJ4MFBmejNnV0JpR0xRSHNQQlpNclNxOXIyNWFWX3FrQ3lyRVA2TUtaZnJKMnppVF8xaGFYWHBXenZRUlprS1RkVnZfZlBFZnlINzY0WjQzZW5OV1R5eTJJU0kzSkZrcHdkdw?oc=5","date":"2025-12-07","type":"trial","source":"Genetic Engineering and Biotechnology News","summary":"StockWatch: Cosmo Surges 40% on Baldness Candidate’s Phase III Data - Genetic Engineering and Biotechnology News","headline":"StockWatch: Cosmo Surges 40% on Baldness Candidate’s Phase III Data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5mRi1vMzFhcXZOTzlCMlFsVWE2X3haeFdDdTBqdFBFLXN6STVkWS1ROXpKWmQzNkhBa2hnQ0JjVzNOZVNhYXVJWUNBY3JfRUg2TFdHWlBnSkw0bnRlZU1xaFRHN01pRUxkOXZaQy0zM2RUM3V3Q2FtLTdhYw?oc=5","date":"2025-12-04","type":"pipeline","source":"Yahoo Finance","summary":"3 Large Drug Stocks to Watch as the Industry Shows Some Recovery - Yahoo Finance","headline":"3 Large Drug Stocks to Watch as the Industry Shows Some Recovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOTlZhU3M1MmNEYXI4d1Bnbno3VUw4eVQzQ29rRTM3RDJvMF9LOEdkVXhmMHJ6U2FUWUZkbWdlMk9HT2FrRGUwaXY2bUkzQl9ncEc2OEw1X0p5SWpvWEg4Qk9XWkFSVmx0RHhCVGF4d2ZoaUUtSFlxekxkaWRJeVd1RXVLckswNHlnUE5LNUtn?oc=5","date":"2025-12-04","type":"trial","source":"Gizmodo","summary":"New Baldness Drug Boosted Hair Growth by 539% in Trials - Gizmodo","headline":"New Baldness Drug Boosted Hair Growth by 539% in Trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQRXRNaEpCNE85a0xwamJfajJ4VXVDajRxdkpSZ1FqbkdJR3psSURURFpuX1VfY1MybTVEYkdDaUVqVGJuWjNOVEhYcVdkWXdYSElodTdCVkNzY2pJNzBoaFVOQXNkZ1NqZzJrZldvZVdDTXNySk5EWF9QRTRKSW1zc0xhQUxya2w1bDA1RTRTLW5HdExJS0RpeXFWbGI?oc=5","date":"2025-12-03","type":"trial","source":"statnews.com","summary":"Hair loss drug succeeds in Phase 3, but data underwhelms experts - statnews.com","headline":"Hair loss drug succeeds in Phase 3, but data underwhelms experts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPUzNha2I2UE1YQzVRNjkwbHBEWnVvZjZyUV9NV2lNUFpneGRCUFFLRS1vUzZnb1NucXQtYXowYmtpQzZZaG5oOXo5QjFhQjdtOXhwODNlUkVZWU1MOTdhdkNkNl9YOWRTaVpZWm13RXV0dmQtQXh3XzdEQ2hEMm5UMjFFYVl6LWVra0V0SktRRTJMazN1VWpUV0RNR3pPblBUVjQzUDZjWU54MmI5N1FzaXFXRHBZZWlFaHo4dmhPYnlfcl9rbzBQdw?oc=5","date":"2025-12-03","type":"trial","source":"Investing.com","summary":"Cosmo shares surge over 20% after Breezula Phase III trials hit key goals - Investing.com","headline":"Cosmo shares surge over 20% after Breezula Phase III trials hit key goals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1Ta2ZqSWZFelJDQ0dmb256eC16RXlQSTh4YmhmSExWczhaNjhUTXJjYVl1azcwbEZibF9wb2NSV0xJVkZWRmY0MWh4UjlWSEdVLUlUdkRIX2FDR0VJbldYUXEzR1RwSERSWXRsYkZOeEFocmxmQ0ZHUWFBM3ZqZw?oc=5","date":"2025-11-04","type":"pipeline","source":"The New York Times","summary":"French Pharmacy Skin Care That Actually Deserves the Hype - The New York Times","headline":"French Pharmacy Skin Care That Actually Deserves the Hype","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQMGpRZmJ2MDMyZjQxOVItVnF5R3ppM2pMdGtCd0ZpeElWTEVmMGF0WVc5QmFXNDljZFdxQy1wRElUMHlWQ2NfUFE5c250VlVsbS1ZbTZKeWREMl82MjJqWDZ5R211am4zUThIdktLbVk2eGpHWVZFQmhUc2QzUGFlUDBFT1JXbGM?oc=5","date":"2025-09-07","type":"trial","source":"Yahoo Finance","summary":"Jefferies Raises Price Target for aTyr Pharma (ATYR) Ahead of Study Results - Yahoo Finance","headline":"Jefferies Raises Price Target for aTyr Pharma (ATYR) Ahead of Study Results","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}